Literature DB >> 11763634

[Adverse effects of drugs in patients with heart disease lead to hospital care].

C Sarlöv1, E Andersén-Karlsson, C von Bahr.   

Abstract

Polypharmacy in patients with cardiovascular disease leads to an increased risk of developing adverse effects. At the Department of Internal Medicine at Stockholm Söder Hospital we studied computerized records and discovered that 14% of those hospitalized patients who were on drug treatment for cardiovascular diseases were admitted due to problems or symptoms possibly caused by their drugs. Interactions were less common; the symptoms which warranted hospitalization were more often caused by additive pharmacological effects. Obviously, adverse effects of drugs decrease quality of life, cause unnecessary suffering and treatment, and are expensive for the health care system. Screening of computerized records helps us detect adverse effects, and facilitates prevention.

Entities:  

Mesh:

Year:  2001        PMID: 11763634

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  3 in total

1.  Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Authors:  Jonny Olsson; Asa Bergman; Anders Carlsten; Thimothy Oké; Cecilia Bernsten; Ingrid K Schmidt; Johan Fastbom
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study.

Authors:  Anders Helldén; Ulf Bergman; Mia von Euler; Maria Hentschke; Ingegerd Odar-Cederlöf; Gunnar Ohlén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450].

Authors:  Jørund Straand; Arne Fetveit; Sture Rognstad; Svein Gjelstad; Mette Brekke; Ingvild Dalen
Journal:  BMC Health Serv Res       Date:  2006-06-11       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.